Extremity Medical
$672.9K 438 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Verathon Inc.
Verathon Inc. reported $672,806.19 across General Payments, Research, and Ownership to 134 physicians and teaching hospitals across 134 transactions.
- $672.8K Above-median payer
- All-tracks total
- 134 Below-median volume
- Transactions
- 134 Below-median reach
- Recipients
- +$276.6K
- General Payments vs PY2023
Verathon Inc. reported $672,806.19 across all CMS Open Payments tracks (General + Research + Ownership) to 134 physicians and teaching hospitals in Program Year 2024 - ranking #700 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $672,806.19, averaging $5.0K per recipient.
Verathon Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
15/100
Total payments
F
16/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer verathon-inc Verathon Inc.
$672.8K · #700/1,925 · 0.0% industry · PY2024
- TOT $672.8K
- RANK #700
- SHARE 0.0%
- TXN 134
- RCP 134
- CAT 2
- GEN $672.8K
- ΔGEN +$276.6K
- TOP1 58.0%
- PY 2024
Volume peers
Nearest volume peer: Extremity Medical ($672.9K)
Verathon Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Verathon Inc.'s CMS-reported General Payments increased by $276.6K (+69.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VERATHON INC.PY2023: VERATHON INC.PY2024: Verathon Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $396,194.99
- PY2024
- $672,806.19
What the Data Shows for Verathon Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Verathon Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $590.3K across 132 transactions, 87.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Verathon Inc.'s 2-category general-payment breakdown at $590.3K, 87.7% of the reported total.
How Verathon Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $590.3K | 132 | 87.7% |
| Grant | $82.5K | 2 | 12.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $535,092.00 (79.5%) of $672,806.19 in this company's General Payments records across 87 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Verathon Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jeffrey Spencer
$390,550.00 across 6 reported transactions
- 2
Richard Conner
$45,450.00 across 4 reported transactions
- 3
Joseph Esherick
$43,241.00 across 1 reported transactions
- 4
Dennis Taylor
$39,251.00 across 1 reported transactions
- 5
Mark Ramzy
$16,600.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Verathon Inc.'s spend rank (#700 of 1,925, top 36% by spend) and concentration rank (#501 of 1,838, top 27% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Therakos Healthcare LLC : $35.7K total payments, HHI 3564
- CMF Medicon Surgical Inc. : $9.8K total payments, HHI 3560
- Fresenius Kabi USA, LLC : $1.3M total payments, HHI 3555
- Immunocore Limited : $1.1M total payments, HHI 3543
- GastroGPO, LLC : $3.7K total payments, HHI 3528
- Pfizer Chile S.a. : $16.9K total payments, HHI 3528
- Verathon Inc. (this company) : $672.8K total payments, HHI 3520
- J. Morita USA, Inc. : $88.2K total payments, HHI 3500
- DTE Oregon, Inc. : $304.57 total payments, HHI 3497
- Alcon Research LLC : $7.1M total payments, HHI 3482
- Winter Innovations, Inc. : $4.7K total payments, HHI 3468
- ONY Biotech Inc. : $39.6K total payments, HHI 3464
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Verathon Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Verathon Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Verathon Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Synapse Surgical LLC
$674.2K 0 recipients
Compare payment profiles
Teleflex Incorporated
$670.6K 117 recipients
Compare payment profiles
Aesculap Implant Systems, LLC
$670.4K 222 recipients
Compare payment profiles
Vascular Graft Solutions Inc
$668.1K 2 recipients
Compare payment profiles
Tempus AI, Inc
$683.5K 14,627 recipients
Compare payment profiles
Put this to use
Verathon Inc. ranks #700 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Verathon Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.